09/02/2025
September is Childhood Cancer Awareness Month.
The Danbury Proton team (www.DanburyProton.com) looks forward to the day when we're ready to open and serve pediatric and other patients. It's still quite a while away, but every day, we are making significant progress in pursuit of that vision!
According to the National Association for Proton Therapy (NAPT), proton therapy has become the standard of care for pediatric cancer patients because of its ability to target tumors with exceptional precision while minimizing damage to healthy tissue. This is particularly important for children and young adults, whose bodies are still developing.
Over 80% of children diagnosed with cancer now survive at least five years, and 70% can expect to become long-term survivors. Proton therapy plays a vital role in contributing to this improved survival, as it reduces the risk of long-term side effects, such as growth issues, cognitive delays, and the development of secondary cancers, which are often associated with traditional radiation therapies.
Since 1975, the overall death rate for childhood cancer has decreased by more than 50%. Proton therapy is especially valuable for treating cancers located near critical areas, such as the brain, spine, and eyes, where minimizing exposure to surrounding healthy tissue is crucial.
With decades of research supporting its efficacy and safety, proton therapy is recommended by leading cancer institutions around the world as the preferred treatment for pediatric patients, helping them not only survive their diagnosis but thrive after treatment.
To learn more, please visit https://proton-therapy.org/pediatric-proton-therapy/ .